wlt_thumbnail-608
Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterp
City Mumbai
Phone +91 22 2653 4444
Website www.wockhardt.com
Contact Person Name Dr. Habil Khorakiwala
Country India
State/Province Maharashtra
distance: 630 Kilometers

Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals.
Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 8600 Wockhardt Associates from 21 different nationalities globally. It has 3 research centres and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines.
Wockhardt is a business in transition. New and innovative business models are in motion to make the most of emerging opportunities. A new drive for growth today permeates every mind-set, process and techno-innovation within Wockhardt.
At Wockhardt, we are looking at new ways of thinking, new ways of working and new ways to touch people’s lives.
Wockhardt’s Founder Chairman and Group CEO, Dr. Habil Khorakiwala says, “A decade ago, I saw a changing world that I believed would present us with large-scale future opportunities in the field of pharmaceuticals and biotechnology. We steered our business model to leverage our research capabilities in providing innovative solutions and by constantly upgrading our world-class manufacturing facilities. We ventured outside India systematically and positioned ourselves mainly in the European and the US markets, which currently generates over 76% of our revenues.” 
Headquatered in Mumbai, India, Wockhardt has full-fledged operations in the USA, UK, Ireland and France. It also has its marketing presence in emerging markets of Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait.
Wockhardt’s core business is innovation. It uses science and technology to develop medicines and other products that improve the quality of millions people’s lives through better health.
Wockhardt has proved its technical excellence by developing patented modified release formulations and recombinant biotechnology products. It has a multi-disciplinary R&D programme with more than 607 scientists, including over 80 doctorates, in the areas of:
Pharmaceutical Research
Biotechnology & Genomics Research
Novel Drug Delivery Systems
New Drug Discovery Programme. API Research
Wockhardt is in the forefront of Intellectual Property creation with 1,733 patents filed till date, of which 228 patents have been granted. Our capability and commitment in pursuing Intellectual Property has been recognised by the Government of India for four years in a row, with an award for the maximum number of ‘Patent filings and Grants from India’. Wockhardt is determined to create benchmarks for a promising future.

Send Enquiry Submit your requirements to get a quote.


Business Details


Address

Wockhardt Towers,
Bandra Kurla Complex
Bandra (East)

City Mumbai
State / Province / Region Maharashtra
Country IN
Zip / Postal Code 400051
Phone +91 22 2653 4444
Fax +91 22 2652 3905
Website www.wockhardt.com
Contact Person Name Dr. Habil Khorakiwala
Key Persons / Management

Dr. Habil Khorakiwala - Chairman

Factory / Facilities

Wockhardt Limited
B-15/2, MIDC Waluj
Maharashtra - 431 136.

Country India
State/Province Maharashtra
distance: 630 Kilometers
Address Bandra East, Mumbai, Maharashtra, India
Category , , , , , , , , , , , , ,
Open in Google Maps

Business Location


Subscribe ToBulkdrugs Directory Newsletter

Subscribe ToBulkdrugs Directory Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!